Cargando…

Recombinant protein targeting and opsonizing spike glycoprotein for enhancing SARS-CoV-2 phagocytosis

The present hypothesis suggests an innovative therapeutic strategy to cease Covid 19 infection. It is based on the inhibition of Spike glycoprotein and ACE-2 receptor interaction that provides the entry of virus in human host cells, by targeting the S protein with a recombinant molecule made of the...

Descripción completa

Detalles Bibliográficos
Autor principal:	Khattabi, Latifa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Letter to Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358758/ https://www.ncbi.nlm.nih.gov/pubmed/32721804 http://dx.doi.org/10.1016/j.mehy.2020.110108

Ejemplares similares

FcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia
por: Norris, Peter A. A., et al.
Publicado: (2020)

Spike-Dependent Opsonization Indicates Both Dose-Dependent Inhibition of Phagocytosis and That Non-Neutralizing Antibodies Can Confer Protection to SARS-CoV-2
por: Bahnan, Wael, et al.
Publicado: (2022)

Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein
por: Ruhnau, Johannes, et al.
Publicado: (2021)

Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between the virus and ACE2
por: Hayashi, Takuma, et al.
Publicado: (2021)

SARS-CoV-2 recombinant XN, Italy
por: Novazzi, Federica, et al.
Publicado: (2022)

Reply to Hayashi and Konishi: Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between virus and ACE2
por: Tang, Yan-Dong
Publicado: (2021)

Loss of Spike N370 glycosylation as an important evolutionary event for the enhanced infectivity of SARS-CoV-2
por: Zhang, Shuyuan, et al.
Publicado: (2022)

SARS-CoV-2 spike protein interacts with and activates TLR41
por: Zhao, Yingchi, et al.
Publicado: (2021)

SARS‐CoV‐2 infection in lung transplant recipients induces circulating exosomes with SARS‐CoV‐2 spike protein S2
por: Bansal, Sandhya, et al.
Publicado: (2021)

Myelin oligodendrocyte glycoprotein associated disorder following SARS-CoV-2 vaccination
por: Bellakhdar, S., et al.
Publicado: (2022)

Expression, Glycosylation, and Modification of the Spike (S) Glycoprotein of SARS CoV
por: Shen, Shuo, et al.
Publicado: (2007)

Controlling the SARS-CoV-2 Spike Glycoprotein Conformation
por: Henderson, Rory, et al.
Publicado: (2020)

Controlling the SARS-CoV-2 spike glycoprotein conformation
por: Henderson, Rory, et al.
Publicado: (2020)

Heme binding to the SARS-CoV-2 spike glycoprotein
por: Freeman, Samuel L., et al.
Publicado: (2023)

PQQ Supplementation and SARS-CoV-2 Spike Protein-Induced Heart Inflammation
por: Boretti, Alberto
Publicado: (2022)

Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity
por: Scherlinger, Marc, et al.
Publicado: (2023)

Glycosylation is key for enhancing drug recognition into spike glycoprotein of SARS-CoV-2
por: Ropón-Palacios, Georcki, et al.
Publicado: (2022)

Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals
por: Faustini, Sian, et al.
Publicado: (2022)

Structure of SARS-CoV-2 Spike Glycoprotein for Therapeutic and Preventive Target
por: Hong, Jaewoo, et al.
Publicado: (2021)

Plasma fibronectin enhances phagocytosis of opsonized particles by human peripheral blood monocytes
Publicado: (1983)

Bimodular effects of D614G mutation on the spike glycoprotein of SARS-CoV-2 enhance protein processing, membrane fusion, and viral infectivity
por: Jiang, Xiaoyi, et al.
Publicado: (2020)

Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients
por: Zhang, Bao-zhong, et al.
Publicado: (2020)

SARS-CoV-2 Spike Antibody Levels Trend among Sinopharm Vaccinated People
por: Saeed, Umar, et al.
Publicado: (2021)

Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein
por: Wrobel, Antoni G., et al.
Publicado: (2020)

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
por: Walls, Alexandra C., et al.
Publicado: (2020)

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
por: Walls, Alexandra C., et al.
Publicado: (2020)

Evolutionary Dynamics of Indels in SARS-CoV-2 Spike Glycoprotein
por: Rao, R Shyama Prasad, et al.
Publicado: (2021)

Uncovering cryptic pockets in the SARS-CoV-2 spike glycoprotein
por: Zuzic, Lorena, et al.
Publicado: (2022)

Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein
por: Calvaresi, Valeria, et al.
Publicado: (2023)

Conformational stability of SARS-CoV-2 glycoprotein spike variants
por: Arruda, Hiam R.S., et al.
Publicado: (2022)

Using Spike Gene Target Failure to Estimate Growth Rate of the Alpha and Omicron Variants of SARS-CoV-2
por: Smith, Benjamin F., et al.
Publicado: (2022)

Bromelain inhibits SARS‐CoV‐2 infection via targeting ACE‐2, TMPRSS2, and spike protein
por: Sagar, Satish, et al.
Publicado: (2021)

Glycoprotein molecular dynamics analysis: SARS-CoV-2 spike glycoprotein case study
por: Coutinho, João Victor Paccini, et al.
Publicado: (2022)

Production of Recombinant Replication-defective Lentiviruses Bearing the SARS-CoV or SARS-CoV-2 Attachment Spike Glycoprotein and Their Application in Receptor Tropism and Neutralisation Assays
por: Thakur, Nazia, et al.
Publicado: (2021)

Opsonizing antibodies mediated SARS‐CoV‐2 entry into monocytes leads to inflammation
por: Yao, Tong, et al.
Publicado: (2022)

Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
por: Zheng, Ming, et al.
Publicado: (2020)

Restructuring the ONYX-015 adenovirus by using spike protein genes from SARS-CoV-2 and MERS-CoV: Possible implications in breast cancer treatment
por: Parmar, Hamendra Singh, et al.
Publicado: (2022)

Peptide Targets to SARS-CoV-2
por: Mandal, Santi M.
Publicado: (2020)

O-glycosylation pattern of the SARS-CoV-2 spike protein reveals an “O-Follow-N” rule
por: Tian, Wenmin, et al.
Publicado: (2021)

Host-cell recognition of SARS-CoV-2 spike receptor binding domain from different variants
por: Elfiky, Abdo A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3eolah0redrtam103m030525mg